With regard to aging rate, a measure of population decline, Japan is by far the leading country compared to Italy (23.6%), Germany (21.7%), the United States (16.6%) and China (11.9%). Meanwhile, malignancies and cardiovascular diseases are the leading and second leading causes of death in every country. In addition to cancer, how should medical care respond to the elderly who suffer from dementia and age-related degenerative diseases? To what extent is it acceptable in terms of health economics to apply expensive medical treatments such as molecular-targeted drugs, genome medicine, and robotic surgery to elderly cancer patients? What is the true purpose of cancer treatment in a super-aging society? We will discuss the direction we should take across national and cultural boundaries.


*Timetable is subject to change.

*For system reasons, the maximum number of participants who can join online (Zoom) is limited to 100.

If you wish to participate, please enter the room as soon as possible.